COVID-19, funding shortfalls are devastating efforts to end Tuberculosis by 2030 – report

The Stop TB Partnership today released new data showing how the COVID-19 pandemic and dismally low levels of funding represent the main barriers to achieving the United Nations Sustainable Development Goals of ending TB by 2030. The data from 2021 shows that the impact of COVID-19 on the TB response has continued to be profound: 1.2 million fewer people have been diagnosed and treated for TB in in 2021 with four months still left in the calendar year. Currently, only

Five ways to tackle vaccine hesitancy

The reluctance or refusal to accept Covid-19 vaccinations can be tackled by a five-pronged strategy to addressing the behavioural and socio-demographic factors behind vaccine hesitancy. Writing in the Journal of the Royal Society of Medicine, a group of population health, demographic, epidemiology and behavioural scientists propose an approach focused on confidence, complacency, convenience, communication and context. While confidence in the safety and efficacy of vaccines is crucial, they write, complacency, particularly among younger people and those of lower socioeconomic status, is

COVID-19 reverses 12 years of impressive gains in the fight against tuberculosis

A new report has provided insights into the impact that the COVID-19 pandemic has had on tuberculosis prevention and control measures. According to the report released by the Stop TB Partnership, nine of the countries with the most tuberculosis (TB) cases—representing 60% of the global TB burden—saw a drastic decline in diagnosis and treatment of TB infections in 2020, ranging from 16%-41% (with an average of 23%). The drop brought the overall number of people diagnosed and treated for TB